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Object. Absorbable topical hemostatic agents are commonly used in neurosurgery. In this study the authors ex­
amine the longitudinal relaxation time (T1) of blood in contact with these agents over time, measured in vitro, to de­
termine if their presence could affect the interpretation of postoperative magnetic resonance (MR) images.
Methods. Coagulated and anticoagulated blood were used, both oxygenated and deoxygenated. The effects of a 
collagen-based agent (Collastat) and a cellulose-based agent (Surgicel) on the pH and T1 values of blood and on 
those of saline (used as a control) were investigated. The T1 was measured as a function of magnetic field strength 
and time by using a field-cycling relaxometer. This instrument measures 1/T1, the rate of T1, from which the T1 value 
is computed. The T1 values of blood were compared with those of hemostat-induced blood clots and with those of 
both gray and white matter of the brain. Signal changes on T1-weighted MR images were predicted on the basis of 
altered T1 values in vitro. Postoperative images were visually examined for the predicted changes. With the addi­
tion of Surgicel, blood had decreased pH and significantly shortened T1 at all fields, essentially within minutes, al­
though it affected the T1 of saline only minimally. The effect of Surgicel increasingly shortened the T1 for 4 days in 
oxygenated blood. Collastat had no significant effect. The presence of some paramagnetic methemoglobin in Sur- 
gicel-induced clots was demonstrated using the relaxometer at a time when diamagnetic oxyhemoglobin would be 
present in naturally occurring blood clots. A bright signal that could mimic residual tumor on contrast-enhanced im­
ages was predicted and confirmed on postoperative T1-weighted MR images obtained in patients in whom Surgicel 
lined the tumor bed. It was not present in cases in which Surgicel was not used.
Conclusions. Surgicel alters the appearance of early postoperative MR images. To avoid misinterpretation, clini­
cians should be aware of this phenomenon.
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A b s o r b a b l e  topical hemostatic agents are used in all surgical specialties to achieve hemostasis. Some of these agents are collagen based (microfibril or 
sponge) and others are gelatin or cellulose based. Which 
agent is used in a particular surgical intervention depends 
on many factors, including ease of application, bioabsorp­
tion, antigenicity, and tissue reaction.
In the present in vitro study we investigated the effect of 
absorbable hemostatic agents on the proton T1  of blood.22 
We hypothesized that these agents may alter the proton T1  
of clotting blood and the time course of these durations. 
Thus, the presence of absorbable hemostatic agents might 
affect the interpretation and optimal timing of postopera­
tive MR images because blood products in the surgical bed 
may produce altered MR signal characteristics.
The effects of a collagen-based sponge (Collastat) and 
oxidized regenerated cellulose (Surgicel) on the T1 of blood 
and saline (used as a control) and on the time course of T1
Abbreviations used in this paper: MR = magnetic resonance; 
NMRD = nuclear magnetic relaxation dispersion; T1 = longitudinal 
relaxation time; 1/T1 = longitudinal relaxation rate; T2 = transverse 
relaxation time.
as a function of magnetic field strength were investigated. 
Our goal was twofold: 1) to compare the T1  values of coag­
ulated and anticoagulated blood with those of hemostat- 
induced blood clots and with those of gray and white mat­
ter of the brain;16 and 2) to evaluate the implications of 
these in vitro data for timing and interpretation of in vivo 
postoperative MR images.
Materials and Methods
After approval for the study had been obtained from the internal 
review board of New York Medical College, venous blood was 
drawn from a healthy human volunteer who had not ingested any 
platelet-active drugs during the previous 10 days. The fasting value 
of the hematocrit, hemoglobin concentration, red and white blood 
cell counts, and sedimentation rate were determined by routine clin­
ical analysis. Blood was collected either in a vacutainer containing 
sodium heparin as the anticoagulant (Becton Dickinson Vacutainer 
Systems, Franklin Lakes, NJ) or in a test tube and used fresh imme­
diately. As the blood clotted and the clot retracted, serum was re­
moved by blotting with absorbent paper. For clinical relevance, 
whole blood was studied while fully oxygenated (kept in an at­
mosphere of 95% oxygen/5% carbon dioxide) as well as while ful­
ly oxygenated and anticoagulated. To elucidate different relaxation
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Fig. 1. Graphs demonstrating 1/Tj NMRD profiles, at 35°C, of 0.6 ml of heparinized, oxygenated human whole blood 
and saline before and after exposure to a 20-mg collagen-based sponge (Collastat; left) or 75 mg of oxidized regenerat­
ed cellulose (Surgicel; right). The time, in hours after the hemostatic agents were added, is indicated to the right of the 
ordinate. Collastat increased the 1/T1 value of blood only slightly, whereas Surgicel caused a rapid increase in the values 
of 1/T1 at all fields. The dotted and dashed lines (right) indicate the low- and high-field values of 1/T1 for human white 
matter (WM) and gray matter (GM) of the brain (Koenig, et al., 1990). Note that the lines of the 1/T NMRD profiles 
simply connect the data points and should not be interpreted as an exact fit to the data.
contributions, blood was studied after it had been both deoxygenat­
ed and completely reduced (by addition of 5 mg Na-dithionite/ml 
blood3 and kept in an atmosphere of nitrogen), and deoxygenated 
and anticoagulated.
Two commercially available absorbable topical hemostatic agents 
were used: a collagen-based sponge (Collastat; Vitaphore Wound 
Healing, Inc., Chicago, IL) and oxidized regenerated cellulose (Sur­
gicel; Ethicon, Johnson & Johnson, Somerville, NJ). Twenty milli­
grams of Collastat or 75 mg of Surgicel were added in vitro to 0.6 ml 
of human whole blood or physiological saline. These amounts were 
found to be sufficient to gel the sample volume homogeneously and 
to minimize multiexponential proton relaxation.
The inverse of the proton Tj, termed the “longitudinal relaxation 
rate” or 1/T1, was measured as a function of magnetic field strength 
over the field range of 0.24 mT to 1.2 T (corresponding to a range 
of 0.01 to 50 MHz proton Larmor frequency) by using a field-cy­
cling relaxometer. Using this instrument, the 1/T1 can be measured 
at low field strengths with a high field sensitivity.1214 The resulting 
profiles are known as 1/T1 NMRD profiles. Because the longitudi­
nal relaxation rates (1/TJ, but not the longitudinal relaxation times 
(T1), are additive for different relaxation contributions, we used the 
former in this study. Each reported value of 1/T1 represents the fit of 
a single exponential to the magnetization data, with the error of this 
fit recorded as well. To minimize multiexponential relaxation, red 
blood cells in anticoagulated blood had to be prevented from set­
tling during the measuring time by gently moving such samples ap­
proximately every 5 minutes.
The 1/T1 NMRD profiles were followed in vitro for all samples 
over a period of 3 weeks, the amount of time it takes in vivo for 
fresh blood to evolve from the acute phase through the subacute 
phase to the chronic phase. To evaluate the implications of the 1/T1, 
measured in vitro for postoperative MR images, we used data gen­
erated during the first 4 days. Changes in signal intensity on T1- and 
T2-weighted images were predicted from changes in the 1/T1 at the 
highest and lowest field strengths of the relaxometer, respectively. 
(Note that the 1/T1 measured at the lowest field is related to the 1/T2 
measured at imaging fields.13 A high value of 1/T1 at low fields cor­
relates with shortening of the T2 and a darker signal on T2-weighted
MR images; a high value of 1/T1 at high fields results in signal 
brightness on T1-weighted images). Signal changes, predicted on 
the basis of the in vitro 1/T1, were compared with those visually ob­
served on MR images of naturally occurring blood clots8 9 in vivo 
and on postoperative MR images obtained in patients from whom 
tumors had been excised, with and without placement of hemostat­
ic agents in the tumor bed.
The samples of blood and saline, with or without addition of he­
mostatic agents, were kept in an atmosphere of oxygen or nitrogen 
gas in tightly stoppered test tubes at 35°C. The pH was measured 
using a pH meter (Thermo Orion, Beverly, MA) before and 15 min­
utes after addition of the hemostatic agents. To determine the influ­
ence of a low pH on the 1/T1 NMRD profile of blood, the pH of one 
sample was adjusted with hydrochloric acid to the low pH value of 
blood in contact with Surgicel before the 1/T1 was measured.
Results
Proton Relaxation in Blood Containing Hemostatic Agents
The effect of a 20-mg collagen-based sponge (Colla­
stat) or 75 mg of the oxidized regenerated cellulose (Sur­
gicel) on the 1/Tj of 0.6 ml of blood or saline was investi­
gated as a function of magnetic field strength and time. 
The addition of Surgicel increased the 1/Tj of oxygenated 
blood significantly at all fields, essentially within minutes, 
although it increased the HT1 of saline only minimally. By 
contrast, Collastat increased the 1/Tj of both blood and 
saline only slightly. These qualitatively different effects of 
Surgicel and Collastat on the 1/T values were observed 
in both coagulated and anticoagulated blood; but the dif­
ference was best demonstrated in anticoagulated blood, 
which has a constant water content and 1/Tj during the 
first 24 hours because the blood does not clot.
The effects of Collastat and Surgicel on the 1/Tj values
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Fig. 2. Graphs depicting the values of 1/T1 at the lowest (0.24 mT, left) and highest (1.2 T, right) field strengths of the 
relaxometer plotted against time for 0.6 ml of oxygenated, human whole blood without hemostatic agents (open circles) 
and after addition of 75 mg of Surgicel or 20 mg of Collastat. During the first 4 days, the 1/T1 values of the Collastat-in- 
duced blood clot are comparable to those of a naturally occurring blood clot, whereas those of the Surgicel-induced clot 
are higher. The 1/T1 values are shown for both white matter and gray matter of the brain.
of anticoagulated whole blood and saline were determined 
as a function of magnetic field strength (Fig. 1). The pro­
files of Collastat and blood were essentially additive and, 
therefore, no interactions occurred. By contrast, the pro­
files of Surgicel and blood were not additive. With Surgi- 
cel an interaction must have occurred within the first 0.5 
hour. Furthermore, the shape of the 1/T1 NMRD profile 
of the Surgicel-induced blood clot (Fig. 1 right) changed 
within the first 2 hours, indicating a transition from most­
ly rotationally mobile (0.5-hour profile) to immobilized 
protein (2-hour profile).14 The errors in the 1/Tj values of 
saline were 0.5 to 0.8%, those of blood 0.6 to 1.2%, and 
those of the Collastat-induced clot 0.7 to 1.5%, depending 
on field strength. For the Surgicel-induced clot the error of 
the fit to a single exponential 1/T1 ranged between 2% and 
4.5%, indicating multiexponential proton relaxation.
The time courses of the 1/T1 values at the lowest and 
highest field strengths measured by the relaxometer were 
determined for fully oxygenated, coagulated whole blood 
in vitro, with and without addition of hemostatic agents 
(Fig. 2). The 1/T1 values of the Collastat-induced clot and 
the naturally occurring blood clot were comparable at both 
low and high fields and were similar to those of gray mat­
ter of the brain during Day 1, increasing to those of white 
matter during the next 3 days. By contrast, the 1/T1 val­
ues of the Surgicel-induced clot were significantly higher; 
starting with white matter rates, they increased steadily at 
both low and high fields, on Day 4 reaching values that a 
fully retracted naturally occurring blood clot without he­
mostatic agents would approach only after 3 weeks in this 
in vitro experiment.
The pH o f Blood Containing Hemostatic Agents
When 20 mg of Collastat was added to 0.6 ml of fresh
human blood, the pH changed from 7.45 ± 0 . 1  to 7.4 ±  
0.2 in nonheparinized blood and from 7.5 ± 0 . 1  to 7.2 ±  
0.2 in heparinized blood (3 samples each). When 75 mg of 
Surgicel was added to 0.6 ml of blood, the pH dropped to 
3.7 ± 0 . 1  in nonheparinized blood (six samples) and to 
3.9 ± 0 . 1  in heparinized blood (three samples). Collastat 
reduced the pH of saline and heparinized saline by only
0.2, whereas Surgicel reduced the pH of saline from 5.5 to 
1.3 and the pH of heparinized saline from 6.8 to 1.7. Thus, 
in the amounts used, oxidized regenerated cellulose (Sur- 
gicel) lowered the pH of blood and, even more so, of sa­
line significantly, whereas the collagen-based fleece (Col- 
lastat) did not.
Interaction of Blood and Surgicel
When the 1/T1 NMRD profile of human oxygenated 
whole blood was measured after the pH was adjusted to 
the same low value of the Surgicel-induced blood clot (pH 
4), it was found that the low pH accounted for 50% of the 
initial increase in the 1/T1 at the high field (0.5-hour pro­
file; Fig. 1 right), but did not increase the 1/T1 at the low 
field significantly. The high-field values of the 1/T1 of the 
Surgicel-induced clot could be explained by a paramag­
netic relaxation contribution from methemoglobin during 
Day 1. To test this hypothesis, four Surgicel-induced blood 
clots were prepared: 75 mg of Surgicel gauze was added 
to each of two 0.6-ml samples of fully oxygenated whole 
blood (kept in an oxygen atmosphere) and to two samples 
of fully reduced, deoxygenated blood (reduced by ad­
dition of 5 mg Na-dithionite/ml blood,3 and kept in a ni­
trogen atmosphere). One sample in each group was hep- 
arinized. Because only diamagnetic oxyhemoglobin can 
oxidize to paramagnetic methemoglobin, the rate increase
J. Neurosurg. /  Volume 95 /  October, 2001 689
M. Spiller, et al.
10
TIME (h rs )
Fig. 3. Graph demonstrating the values of 1/Tj at the highest 
field strength of the relaxometer (1.2 T) plotted against time (first 
4 days) for four Surgicel-induced blood clots: two clots with ful­
ly oxygenated blood, kept in an atmosphere of 95% oxygen/5% 
carbon dioxide and two clots with completely deoxygenated blood, 
which was reduced by addition of 5 mg Na-dithionite/ml blood and 
kept in a nitrogen atmosphere. Heparinized blood was used for one 
sample in each group. The 1/T1 increases progressively in the oxy­
genated Surgicel-induced clots, but not in the deoxygenated clots. 
The 1/T1 values are shown for both white and gray matter of the 
brain (Koenig, et al., 1990).
caused by interaction with Surgicel at the high field was 
expected to be much larger in oxygenated blood than in 
fully reduced, deoxygenated blood. These predictions were 
confirmed.
Figure 3 shows the value of 1 /T1  at 1.2 T, the highest 
field strength of the relaxometer, plotted against time, for 
two oxygenated and two reduced, deoxygenated Surgicel- 
induced blood clots (one clot of each group was heparin- 
ized). The 1 /T1  increased steadily during the first 4 days in 
the oxygenated Surgicel-induced clots, whereas no such 
increase occurred in the completely reduced, deoxygenat­
ed clots. An almost constant increase in the 1 /T1  appeared 
in both heparinized samples when compared with the 1 /T1 
values of the corresponding nonheparinized samples, sug­
gesting that heparin may also interact with Surgicel. When 
Surgicel was added to partly deoxygenated blood ( 2.5 
mg of Na-dithionite/ml blood,3 and kept in a nitrogen at­
mosphere), the 1/T1 increased with a variable time course 
(data not shown).
Implications fo r Interpretation of MR Images
Signal intensities of blood clots with and without addi­
tion of hemostatic agents were estimated for T2- and T1- 
weighted MR images from the 1 /T1  values shown in Fig.
2. From these data one predicts the occurrence of a hypo- 
to isointense signal when compared with that of brain for 
the naturally occurring blood clot, as observed in intracra­
nial hematomas,8,9 and for the Collastat-induced clot, but
an increasing hypointense signal on T2-weighted and an 
increasing hyperintense signal on T1 -weighted MR images 
for the Surgicel-induced clot during Days 1 through 4. Vi­
sual inspection of postoperative images, which were ob­
tained 24 to 48 hours after surgery for intracranial tumors 
in two patients, revealed the bright signal predicted on T1 - 
weighted images when Surgicel was used (Fig. 4 lower).
The preoperative sagittal image of a large right cerebel­
lar tumor in a 23-month-old girl after injection of contrast 
agent is shown in Fig. 4 upper left. Postoperative images 
were obtained before and after injection of contrast agents 
24 hours after gross-total resection of a large pilocytic as­
trocytoma (Fig. 4 upper center and upper right). For this 
patient, the surgeon used no absorbable hemostatic agents. 
Postoperative coronal images were obtained before and 
after injection of contrast agents 30 hours after gross-total 
resection of a left occipital metastatic carcinoma in a 52- 
year-old man (Fig. 4 lower). For this patient, the surgeon 
lined much of the tumor bed with Surgicel gauze, result­
ing in the appearance of a bright rim around most of the 
resection cavity on early T1 -weighted postoperative im­
ages (Fig. 4 lower left). After injection of contrast agent, 
no additional enhancement was noted on the T1 -weighted 
images of either patient, confirming gross-total resection. 
The T2-weighted images were unrevealing.
Discussion
Hemostatic Agents in Blood
All topical hemostatic agents primarily aid the quick 
formation of an occlusive plug. The efficacy of different 
hemostatic agents has been evaluated in animals,1,5,6,21,25 
and tissue responses have been reported for a variety of 
sites.7,18,19,24 In in vivo studies of hemostatic efficacy, colla­
gen-based agents have generally proved superior to gela­
tin- and cellulose-based agents, despite different handling 
characteristics.1,11,20,24 Comparative in vitro studies yielded 
a similar overall ranking: collagen-based agents (sponges 
or microfibrils) exceeded Gelfoam, which in turn worked 
more effectively than oxidized regenerated cellulose (Sur-
gicel).23
Oxidized regenerated cellulose (Surgicel), a homoge­
neous soft knitted gauze, is the absorbable topical he­
mostatic agent preferred in cranial surgery. Its chemical 
composition consists of polyanhydroglucuronic acid man­
ufactured from pure alpha cellulose. The primary alcohol 
at C6 has been oxidized to a carboxyl group.17 By weight, 
more than 15% of Surgicel is acid. Bjorenson, et al.,2 doc­
umented a significant decrease in the pH of heparinized 
blood, plasma, and serum after contact with Surgicel; and 
these findings are supported by data presented in the pres­
ent study. The reduction in pH is less dramatic in blood 
than in saline because of buffering proteins. Surgicel lib­
erates hemoglobin from red blood cells and removes cal­
cium ions from solution. The hemoglobin and calcium 
unite chemically with the cellulose fibers of the gauze.17 
Presumably because of its acidity, Surgicel can cause in­
flammatory reactions.2
The collagen-based sponge (Collastat) is a nonwoven 
sheet and is much denser than Surgicel; the sponge has 
small and large pores (<  100 jxm) separated by ridges 
of collagen material. It is native collagen obtained from
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Fig. 4. Upper Left: Preoperative contrast-enhanced Tr weighted sagittal MR image demonstrating a large cerebellar 
pilocytic astrocytoma in a 23-month-old girl. Upper Center and Upper Right: Postoperative Tr weighted MR images 
obtained before and after administration of gadolinium, respectively, 24 hours after gross-total resection in the same pa­
tient. No absorbable hemostatic agents were used during surgery. Lower Left and Lower Right: Postoperative T1- 
weighted coronal images obtained 30 hours after gross-total resection of a left occipital metastatic carcinoma in a 52- 
year-old man. Both the unenhanced (lower left) and contrast-enhanced (lower right) studies demonstrate a hyperintense 
signal at the rim of the tumor bed, which was lined with Surgicel after tumor resection. No additional enhancement was 
noted on postoperative contrast-enhanced images obtained in either patient.
bovine tendon, and is used extensively for parenchymal 
bleeding throughout a wide area. It is debatable wheth­
er equal volumes, weights, or surface areas of hemostatic 
agents should be used in comparative in vitro studies. In 
the present investigation, to gel an equal volume of blood 
or saline the amount of Surgicel required was 3.75-fold 
larger by weight than that of Collastat. A homogeneous 
sample volume is required for characterization of a system 
by a single exponential 1/Tj when measured using a relax- 
ometer.
Proton Relaxation in Blood With and Without Addition of 
Hemostatic Agents
Proton relaxation in blood is dominated by the contri­
bution of hemoglobin in red blood cells. In fresh blood, 
hemoglobin is present primarily as diamagnetic oxyhemo­
globin, which evolves during later phases of blood clot­
ting into paramagnetic methemoglobin.10 Blood clotting 
in the test tube varies significantly with experimental con­
ditions, resulting in different levels of clot retraction. The 
addition of sodium heparin, a highly negatively charged, 
conjugated polysaccharide, to fresh blood completely pre­
vents clotting in vitro as it does in vivo. Relaxation rates 
of anticoagulated whole blood were identical to those of 
freshly drawn blood.
Collastat and Surgicel exerted qualitatively and quanti­
tatively different effects on the magnetic field dependence 
of the 1/Tj of anticoagulated blood, even when the 3.75- 
fold larger amount of Surgicel was taken into account 
(Fig. 1). No interaction detectable by water protons oc­
curred between Collastat and blood; the 1/Tj NMRD 
profiles were additive and did not change during Day 1. 
Hemoglobin, presumably present as oxyhemoglobin in 
the Collastat-induced clot (no paramagnetic T1  shortening 
was noted at high fields), remained rotationally mobile. 
By contrast, the 1/Tj of the Surgicel-induced clot changed 
rapidly as a function of magnetic field strength and time 
during Day 1. Interactions between this hemostatic agent 
and blood occurred, were detectable by water protons, and 
affected their 1/T1 dramatically. The magnitude of the 1/T1 
NMRD profiles of the Surgicel-induced clot at the high 
field (Fig. 1 right) and the much larger error measured for 
the 1/T1 of the Surgicel-induced clot could be explained by 
some paramagnetic hemoglobin already present on Day 1, 
along with diamagnetic oxyhemoglobin. In addition, the 
shape of the 1/T1 NMRD profile changed within 2 hours 
from that of rotationally mobile hemoglobin, bending over 
at low fields and dispersing at high fields, to a disper­
sion profile characteristic for immobilized protein14 (poly­
merized, crosslinked, denatured protein) or tissue1214 with
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monotonically increasing low field rates. This finding is 
consistent with reported lysing of red blood cells and he­
moglobin binding to Surgicel.17
The 1/T1 values for oxygenated nonanticoagulated fresh 
blood were time dependent, as expected (Fig. 2). As the 
blood clotted, the clot retracted, and the serum was re­
moved; the hematocrit increased steadily, reaching its final 
concentration (almost double its initial value of 37.9%) 
after 23 hours. The 1/T1 increased accordingly, especially 
at low fields, at which the 1/T1 is proportional to the pro­
tein concentration.412-14 At Days 4 through 8, the 1/T1 in­
creased at all fields, but most prominently at high fields, in­
dicating the presence of paramagnetic hemoglobin.1015 The 
ratio of the low-field to the high-field value of the 1/T1 on 
Day 8 indicates that it is not pure paramagnetic hemoglo­
bin (methemoglobin),15 but a mixture of paramagnetic and 
diamagnetic hemoglobin present during the subacute phase 
in a fully retracted blood clot in vitro. The time dependence 
of the low field and high field 1/T1 values of blood in the 
presence of hemostatic agents (Fig. 2) can be summarized 
from the perspective of water protons: Collastat appears to 
inhibit the formation of paramagnetic methemoglobin (es­
sentially no increase in 1/T1 values during the subacute 
phase; Fig. 2 right), whereas Surgicel appears to speed up 
oxidation of oxyhemoglobin to methemoglobin (increased 
1/T1 values already present during the acute phase; Fig. 2 
right). Based on measurements obtained with the relax- 
ometer, the proof that indeed some diamagnetic oxyhemo­
globin transforms into paramagnetic methemoglobin, es­
sentially within the first half hour when oxygenated blood 
comes in contact with Surgicel, is shown in Fig. 3. This 
proof depended on showing that exposure to Surgicel does 
not result in increased high field 1/T1 when the hemoglo­
bin in blood is present only as deoxyhemoglobin, as it is 
in completely reduced blood in a nitrogen atmosphere. 
The increase in 1/T1 in heparinized Surgicel-induced blood 
clots, both oxygenated and deoxygenated, compared with 
those in the respective nonheparinized samples (Fig. 3) 
may be caused by a possible complex formed by heparin 
with blood proteins and Surgicel.
Implications fo r the Interpretation o f MR Images
The time course of signal intensities of intracranial hem­
orrhage (from the acute phase through the subacute and 
on to the chronic phase) on T1- and T2 -weighted MR im­
ages can be used to date a hemorrhage. The evolution of 
intracellular diamagnetic oxyhemoglobin into paramagnet­
ic deoxyhemoglobin and methemoglobin, accompanied or 
followed by cell lysis and, eventually, hemosiderin accu­
mulation in granulocytes at the periphery,10 affects the 1/T1 
of blood,10 which determines the contrast between intracra­
nial hemorrhage and surrounding tissue in vivo. After sur­
gical resection of a brain tumor, postoperative MR images 
are often obtained to assess the extent of resection and to 
estimate residual tumor volume. Adjuvant therapy may be 
recommended on the basis of these images. The timing of 
postoperative MR imaging is chosen so that blood clots ap­
pear hypo- to isointense when compared with surrounding 
brain, and surgical site inflammation is minimal. On injec­
tion of contrast agent within 24 to 48 hours after surgery, 
ideally only residual tumor will enhance. On the basis of 
the data from the present study, we predict a bright signal
on early postoperative T1-weighted MR images obtained in 
patients in whom Surgicel is used to line the tumor bed, re­
sulting from the almost instant increase in the 1/T1 of blood 
in contact with Surgicel. Figure 4 lower left demonstrates 
that predictions made on the basis of these in vitro data 
hold true for in vivo MR images. The results of this in vitro 
study exaggerate what may happen in vivo, in which blood 
clots differently and the acidity induced by Surgicel would 
be diluted. But low pH alone does not account for the large 
increase in the 1/T1 of blood in contact with Surgicel; in­
stead, the time course of the 1/T1 of clotting blood, which 
we described earlier, has been altered by the early presence 
of some paramagnetic hemoglobin, which binds to Surgi- 
cel at a time when diamagnetic intracellular oxyhemoglo­
bin would be present in the acute blood clot without Sur- 
gicel.
The radiologist in clinical practice usually does not 
know whether an absorbable topical hemostatic agent was 
used during surgery, let alone which one. We have shown 
that, in addition to areas with a disrupted or injured blood- 
brain barrier, such as residual tumor or inflammatory 
lesions, Surgicel-induced blood clots have a bright ap­
pearance on early postoperative T1-weighted MR images 
obtained after administration of contrast agents. Thus, in 
cases in which subtraction of the signal before and after ad­
dition of contrast agent cannot be done accurately, residual 
tumor volume may be overestimated.
Conclusions
Different absorbable topical hemostatic agents affect the 
1/T1 of blood, its magnetic field dependence, and its time 
course differently. When an altered 1/T1 results in signal in­
tensities that can mimic disease, as is the case when Sur- 
gicel interacts with blood, the interpretation of postopera­
tive MR images may be affected. Communication between 
the surgeon and radiologist concerning cases in which such 
an absorbable agent is used is essential to avoid the possi­
bility of image misinterpretation.
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